Clinical Trials Browser

INDUSTRY × Advanced Cancer × Erlotinib Hydrochloride × Clear all

NCT01287546 2017-02-15

A Study of LY2875358 in Participants With Advanced Cancer

Phase 1 Completed

Advanced Cancer